In this podcast, Michael Miller covers all the hot topics surrounding Rapid and Alternative Microbiology Methods in the pharmaceutical industry.

Of course, we also take a deep dive into the brand-new PDA Technical Report 33, released in July 2026.

Among the topics discussed:

• How do you build a business case and calculate the ROI of an RMM?
• Should we say RMM, ARMM, or Modern Methods?
• The Biggest RMM mistakes
• Why is now the right time to adopt RMMs?
• What is a Primary Validation?

And don't miss the Selection of the 4 Best Rapid Microbiology Methods and their challengers.

Enjoy the podcast!

Content :

00:27 Introduction to Rapid Microbiology Methods

03:06 Early Experiences in Pharmaceutical Microbiology

05:41 Regulatory Changes and Their Impact

08:36 Technical Report 33 Overview

11:52 Collaboration with Regulatory Agencies

14:45 The Future of Rapid Microbiology Methods

17:41 Understanding Terminology in Microbiology Methods

20:41 Supplier Collaboration and Industry Expectations

37:36 Validation Protocols and Statistical Analysis

42:04 Success Stories in Pharmaceutical Manufacturing

47:46 The Importance of Rapid Methods in ATMPs

51:25 Challenges in User Requirement Specifications

53:43 Trusting Supplier Validation

56:38 The Future of Rapid Micro Methods

01:00:42 Conferences and Resources for Rapid Microbiology

01:10:25 Conclusion and Future Outlook